FindTrial
Sign In

Research on the accurate diagnosis and evaluation system of congenital syphilis and its clinical application

Research on the accurate diagnosis and evaluation system of congenital syphilis and its clinical application

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036934
Enrollment
Unknown
Registered
2020-08-25
Start date
2021-01-01
Completion date
Unknown
Last updated
2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

syphilis

Interventions

Gold Standard:The gold standard: 1. Positive for TP nucleic acid
2. Make a comprehensive judgment based on epidemiology, signs, symptoms, and other laboratory test results
3.Patients were followed up for 18 months, specific antibody was positive.
Index test:The&#32
evaluation&#32
system&#32
of&#32
accurate&#32
diagnosis&#32
congenital&#32
syphilis&#32
based&#32
on&#32
molecular&#32
biology:&#32
1.TP-PCR
&#32
2.CLIA-TP

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. pregnancy and congenital syphilis; 2. Suspected pregnancy syphilis and congenital syphilis; 3. difference stages of syphilis.

Exclusion criteria

Exclusion criteria: Refuse to sign informed consent.

Design outcomes

Primary

MeasureTime frame
Treponema pallidum DNA;—

Secondary

MeasureTime frame
Syphilitic specific IgM antibody;—

Countries

China

Contacts

Public ContactGu Wei-Ming
weiming_gu2003@aliyun.com+86 18017336651

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026